HY-133
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HY-133, covering 2024-12-06 to 2024-12-06. Get the full timeline:
Most recent: Clinical Trial Update: First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133 [Phase 1]